Resultados: 9

    COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community

    The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic and best use of NHS resources. We have withdrawn our guideline on diagnosing and managing pneumonia in adults until further notice....

    COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community

    The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection....

    COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD)

    The purpose of this guideline is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources....

    Guía para el cuidado crítico de pacientes adultos graves con Coronavirus (COVID-19) en las Américas (Versión larga)

    Esta guía de práctica clínica provee recomendaciones informadas en la evidencia para el control de la infección, recolección de muestras, cuidado de soporte, tratamiento farmacológico y prevención de complicaciones. Las recomendaciones están dirigidas a todo el personal de salud que atiende a los...

    Guidelines for Critical Care of Seriously Ill Adult Patients with Coronavirus (COVID-19) in the Americas (Short version)

    This clinical practice guideline provides evidence-informed recommendations for infection control, specimen collection, supportive care, pharmacological treatment, and prevention of complications. The recommendations are directed to all health care staff who deal with patients in emergency departments an...

    Clinical management of influenza and other acute respiratory illness in resource-limited settings: learning from the influenza pandemic (H1N1) 2009

    Pandemic (H1N1) 2009, the first influenza pandemic of the 21st century, reached all parts of the world within a year, causing epidemics of varying magnitude. During the pandemic period, the World Health Organization (WHO) received reports of over 18 000 laboratory-confirmed deaths due to infection with t...

    Reducing excess mortality from common illnesses during an influenza pandemic WHO guidelines for emergency health interventions in community settings

    Communicable diseases are currently the leading cause of preventable deaths worldwide, disproportionately affecting resource-poor settings. Pandemic influenza would add to already unacceptable levels of morbidity and mortality from diarrhoea, malaria, pneumonia, malnutrition, HIV/AIDS and tuberculosis, i...

    WHO Guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses: part II review of evidence

    This revised guidance is published in two parts. Part II documents the procedures followed in developing this guidance, together with a review of evidence and other new information on the pharmacological agents considered....

    WHO Guidelines for pharmacological management of pandemic Influenza A(H1N1) 2009 and other influenza viruses: part I recommendations

    The purpose of this document is to provide a basis for advice to clinicians on the use of the currently available antivirals for patients presenting with illness due to influenza virus infection, as well their use for chemoprophylaxis. This guidance updates and replaces the recommendations published in A...